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(3) Role of Airway Mucins in Inflammatory Lung Diseases
Kiyoshi Takeyama
Department of Respiratory Medicine, Tokyo Women’s Medical University, Tokyo, Japan
Homeostasis of the airways is maintained through a mucociliary clearance, which is a biological defense system
that traps inhaled fine particles with mucus and eliminates them from the lower respiratory tract by ciliary
movement. However, in airway inflammation, mucin gene expression in mucus-producing cells is stimulated by
various inflammatory mediators, cytokines, growth factors, and reactive oxygen species that are produced by re-
cruited inflammatory cells, such as neutrophils and eosinophils, thereby increasing the production and secretion
of airway mucus. On the other hand, the ciliary transport function is remarkably impaired by inflammatory epi-
thelial cell damage and changes in the biophysical properties of mucus, resulting in an airway hypersecretory
condition. In particular, mucin 5AC, which is produced by goblet cells, plays a central role in the formation of mu-
cus plugs, which contributes to the poor prognosis of airway hypersecretory diseases. Recently, a molecular bio-
logical analysis of airway mucins revealed the function, distribution, and gene regulatory mechanism of mucin in
various pathological conditions of airway inflammation. This paper reviews the mechanism of action underlying
airway hypersecretion and its therapeutic approaches in airway inflammatory diseases.
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Figure　1　Mucociliary transport system in the lower air-
ways.
Two major secreted mucins, MUC5B and MUC5AC, form 
a gel layer with distinct morphological structures. MUC5B 
is secreted by submucosal glands as strands. MUC5AC is
secreted by goblet cells as threads and thin sheets. After
being secreted onto the airway surface, the two mucins 
associate to form a gel layer where MUC5B strands are
partially bundled by MUC5AC sheets. These distinct mor-
phological structures may contribute to efficient mucocili-



























































クである endoplasmic reticulum-to-nucleus signal-




















Figure　2　Role of airway-secreted mucins in health and disease.
Homeostasis of airway epithelium is maintained by two major gel-forming mucins, MUC5B 
and MUC5AC. Both mucins act as a biological defense in a healthy state. However, during 
airway inflammation, excessively produced mucins impair mucociliary transport. MUC5B is 
involved in the honeycomb formation, and MUC5AC is involved in both mucus plug forma-
tion and airway hyperresponsiveness. 
Figure　3　Correlation between EGFR immunoreactivity and MUC5AC production in air-
way epithelium.
EGFR immunoreactivity of airway epithelial cells showed a significant positive correlation 
with the area of MUC5AC-positive staining in airway epithelium (r = 0.725, p < 0.0001).
Reprinted with permission of the American Thoracic Society.
Copyright © 2020 American Thoracic Society. All rights reserved.
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Figure 4 Mechanism of mucus plug formation in patients with asthma.
High levels of IL-13 result in increased production of MUC5AC in goblet cell. The secreted 
MUC5AC-containing mucus gels tether to the goblet cells. IL-13 also increases transport of 
thiocyanate into the airways. The thiocyanate reacts with oxidants induced by activated 
eosinophils, thereby promoting crosslinking of MUC5AC in airway lumen. Both epithelial 











への分化誘導には type 2 T helper cell（Th2）サイト
カインが関与しており，なかでも IL-13はその中心
的役割を果たしている１９）～２２）．また，喘息気道では
MUC5AC産生量と epidermal growth factor recep-
tor（EGFR）の発現量に有意な正の相関が示されて
いる（Figure 3）２３）．気道に集積した好酸球は EGFR







































Figure　5　Signaling pathways of airway MUC5AC expres-
sion by inflammatory cells.
Recruited inflammatory cells are involved in MUC5AC 
expression via the IL-13 and EGFR pathways. In the IL-
13 pathway, Th2 cell-derived IL-13 enhances SPDEF ex-
pression via JAK/STAT6, which subsequently enhances
TMEM16A and CLCA1 expression, and FOXA2 inhibition,
resulting in up-regulation of MUC5AC expression. The 
EGFR pathway is activated by EGFR ligands produced
by eosinophils and mast cells. TGFα is also cleaved from
epithelial cells due to DuoX1-TACE activation caused by
neutrophil-derived elastase and ROS. HIF-1, FOXA2, TMEM





































kinase 1（JAK1）/STAT6を 介 し て sam pointed
domain-containing ETS transcription factor
（SPDEF）の発現が増強し３７）３８），①粘液産生抑制に関



















































Table　1　Potential therapeutic targets to treat airway hypersecretion.
Mechanism of action Current Near future
Elimination of risk factors Smoking cessation 
Indoor cleaning





Inhibition of mucin production Macrolides 47)-49) SPDEF inhibitors 37) 38)
15) 16) 24) 31) 32) 34)-36) 52) EGFR-TKIs CLCA1 inhibitors (Niflumic acid) 56) 
Th2 cytokine inhibitors 53) MAPK13 inhibitors 42)
Anti IL-13 Ab HIF-1 inhibitors (YC-1) 57)
Anti IL-4R Ab
Inhibition of mucin secretion Long acting muscarinic antagonist 50) 51) MARCKS blockades (MANS peptides) 58)
HSP-70 inhibitors (MAL3-101) 59)
TMEM16A inhibitors (T16Ainh-A01) 60)






Currently, stimulation of mucus discharge (mucolytics) is a common treatment strategy for airway mucus hypersecre-
tion. The development of an inhibitor of MUC5AC production is expected in the near future.
EGFR-TKI, epidermal growth factor receptor-tyrosine kinase inhibitor; SPDEF, Sam pointed domain-containing ETS 
transcription factor; CLCA1, calcium-activated chloride channel regulator 1; MAPK13, mitogen-activated protein ki-
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